Glimepiride Accord Healthcare (Glimepiride)

Glimepiride Accord Healthcare is prescribed primarily for the oral management of type 2 diabetes mellitus.

• As monotherapy in patients whose diet and exercise alone do not achieve glycemic control.
• In combination with other oral antidiabetic agents (e.g., metformin) when additional glucose lowering is needed.
• As part of a comprehensive diabetes care plan that includes diet, physical activity, and regular monitoring.
• For adults with established type 2 diabetes to improve fasting and post‑prandial blood glucose levels.

The safety profile of glimepiride includes both common, generally mild reactions and rare but serious adverse events.

Common

• Low blood sugar (hypoglycemia), especially when meals are missed or dosing is excessive.
• Nausea or mild gastrointestinal discomfort.
• Headache or dizziness.
• Weight gain due to increased insulin activity.

Serious

• Severe hypoglycemia leading to loss of consciousness or seizures.
• Allergic reactions such as rash, itching, or swelling.
• Hepatic dysfunction indicated by elevated liver enzymes.
• Hematologic abnormalities like leukopenia or thrombocytopenia.

Before initiating glimepiride, clinicians should evaluate several clinical factors to minimize risks and ensure appropriate use.

• Assess renal and hepatic function, as impairment can increase drug exposure.
• Review patient history for prior sulfonylurea hypersensitivity or severe hypoglycemia.
• Use caution in elderly patients who may be more susceptible to low blood sugar.
• Avoid use during pregnancy or breastfeeding unless benefits outweigh risks.
• Monitor blood glucose regularly during dose adjustments.
• Educate patients on recognizing and managing hypoglycemia symptoms.

Glimepiride may interact with other medicines, altering its effectiveness or safety profile.

Avoid

• Concurrent use with other sulfonylureas or insulin, which can markedly increase hypoglycemia risk.
• Strong CYP2C9 inhibitors (e.g., fluconazole, amiodarone) that raise glimepiride plasma concentrations.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) that may potentiate hypoglycemic effects.

Use with caution

• Beta‑blockers, which can mask hypoglycemia symptoms.
• Thiazide diuretics, which may affect glucose tolerance.
• Antidepressants such as SSRIs that have been reported to influence blood sugar control.